Expert consensus on clinical application of Suhuang Zhike Capsules in treatment of respiratory diseases.
10.19540/j.cnki.cjcmm.20241015.501
- Author:
Yu MING
1
;
Chang-Rui HUANG
2
;
Bang YU
2
;
Wen-Jing CHANG
3
;
Zeng-Tao SUN
4
;
Wei CHEN
3
;
Hong-Chun ZHANG
5
Author Information
1. Institute of Basic Research in Clinical Medicine, China Academy of Chinese Medical Sciences Beijing 100700, China.
2. Beijing University of Chinese Medicine Beijing 100029, China.
3. Center for Evidence-based Medicine, Beijing University of Chinese Medicine Beijing 100029, China.
4. Tianjin University of Traditional Chinese Medicine Tianjin 301617, China.
5. Center of Respiratory Medicine, Department of Traditional Chinese Medicine for Pulmonary Diseases,China-Japan Friendship Hospital Beijing 100029, China.
- Publication Type:Consensus Development Conference
- Keywords:
GRADE;
Suhuang Zhike Capsules;
cough variant asthma;
expert consensus;
post-infectious cough
- MeSH:
Humans;
Drugs, Chinese Herbal/administration & dosage*;
Consensus;
Capsules;
Respiratory Tract Diseases/drug therapy*;
Medicine, Chinese Traditional
- From:
China Journal of Chinese Materia Medica
2025;50(3):817-823
- CountryChina
- Language:Chinese
-
Abstract:
Suhuang Zhike Capsules are widely used in clinical practice for the treatment of respiratory diseases and have been included in Medicine Catalogue for National Basic Medical Insurance, Work Injury Insurance, and Maternity Insurance and National Essential Medicines List. However, problems remain, such as unclear definitions of treatment courses and unidentified contraindications for certain populations. Therefore, this consensus was developed collaboratively by clinical experts in traditional Chinese medicine(TCM) related to pulmonary diseases, respiratory, and critical care medicine, as well as methodology and pharmacy experts, adhering strictly to the consensus development procedures established by the China Association of Chinese Medicine for clinical application of Chinese patent medicines, with the aim to guide the correct clinical use of Suhuang Zhike Capsules for the treatment of cough variant asthma, post-infectious cough, and other respiratory diseases. This consensus employed questionnaire surveys and expert interviews to identify clinical concerns based on the PICOS principle and conduct evidence evaluation and GRADE grading. Utilizing nominal group techniques and GRADE networking methods, it resulted in 17 recommendations and consensus suggestions. The consensus further clarifies the indications, TCM syndromes, usage, and clinical safety of Suhuang Zhike Capsules in the treatment of cough variant asthma and post-infectious cough, aiming to promote standardized medication use and facilitate the rational clinical application of Suhuang Zhike Capsules.
